Page last updated: 2024-08-24

diphenylcyclopropenone and anthralin

diphenylcyclopropenone has been researched along with anthralin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Burkhart, CN; Morrell, DS; Mukherjee, N1
Shapiro, J1
Baba, M; Durdu, M; Özcan, D; Seçkin, D1
Perera, E; Sinclair, R; Yip, L1
Donovan, JC; Spano, F1
Bergfeld, W; Murad, A1
Abedini, R; Ghandi, N; Mirshamsi, A; Nasimi, M; Seirafi, H; Shakoei, S1
Abdelshafy, AS; Esawy, AM; Ibrahim, SA1
Abedini, R; Aryanian, Z; Daneshmand, R; Ghandi, N; Hatami, P; Nasimi, M; Vance, TM1

Reviews

5 review(s) available for diphenylcyclopropenone and anthralin

ArticleYear
Treatment of alopecia areata in children.
    Pediatric annals, 2009, Volume: 38, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anthralin; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Dinitrochlorobenzene; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Minoxidil; Phototherapy; Practice Guidelines as Topic; Treatment Outcome; Vasodilator Agents

2009
Current treatment of alopecia areata.
    The journal of investigative dermatology. Symposium proceedings, 2013, Volume: 16, Issue:1

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups

2013
Alopecia areata.
    Current problems in dermatology, 2015, Volume: 47

    Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Autoimmunity; Cyclopropanes; Cyclosporine; Dermatitis, Allergic Contact; Dermatologic Agents; Humans; Immunosuppressive Agents; Immunotherapy; Injections, Intralesional; Minoxidil; Vasodilator Agents

2015
Alopecia areata: Part 2: treatment.
    Canadian family physician Medecin de famille canadien, 2015, Volume: 61, Issue:9

    Topics: Adult; Alopecia Areata; Anthralin; Child; Cyclopropanes; Dermatologic Agents; Humans; Immunosuppressive Agents; Primary Health Care; Referral and Consultation; Steroids

2015
Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Alopecia Areata; Anthralin; Bimatoprost; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Eyebrows; Eyelashes; Facial Dermatoses; Humans; Latanoprost; Minoxidil; Photosensitizing Agents; Prostaglandins F, Synthetic

2018

Trials

1 trial(s) available for diphenylcyclopropenone and anthralin

ArticleYear
A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    International immunopharmacology, 2021, Volume: 99

    Topics: Adolescent; Adult; Age of Onset; Alopecia Areata; Anthralin; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Female; Hair; Humans; Immunotherapy; Male; Middle Aged; Nail Diseases; Prospective Studies; Treatment Outcome; Young Adult

2021

Other Studies

3 other study(ies) available for diphenylcyclopropenone and anthralin

ArticleYear
Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Anthralin; Apoptosis; CD4-CD8 Ratio; Child; Cyclopropanes; Cytokines; Drug Eruptions; Drug Evaluation; Drug Therapy, Combination; Female; Folliculitis; Follow-Up Studies; Humans; Hyperpigmentation; Immunotherapy; Male; Middle Aged; Pruritus; Retrospective Studies; Severity of Illness Index; T-Lymphocyte Subsets; Treatment Outcome; Young Adult

2015
Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Archives of dermatological research, 2019, Volume: 311, Issue:8

    Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Female; Hair; Humans; Immunologic Factors; Male; Middle Aged; Pruritus; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult

2019
Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
    Dermatologic therapy, 2019, Volume: 32, Issue:5

    Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Child, Preschool; Chronic Disease; Cyclopropanes; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hair; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult

2019